【杂志介绍】
    《Therapeutic Drug Monitoring》是一本经同行评审的多学科期刊，主要面向药理学家、临床化学家、实验室人员、药剂师、药物研究人员和毒理学家人群。刊中收载特定类别药物的评论文章、原创文章、病例报告、技术说明和继续教育文章等。促进了临床药理学、病理学、毒理学和分析化学这些学科之间的知识信息交流。

April2023-Volume45-Issue2（2023年4月第45卷第2期）
https://journals.lww.com/drug-monitoring/toc/2023/04000

      Case Report（案例报告）
      1.治疗性血置换对伊曲康唑药代动力学的影响:一份案例研究
      (Effect of Therapeutic Plasma Exchange on Itraconazole Pharmacokinetics: A Case Study)
      作者：Seah,Vincent MBBS,Sreeharan,Thulashigan BSc (Med) Hons,Kocic,Danijela PhD,Reuter,Stephanie E.PhD,Girgis, Laila PhD,Marriott,Deborah J.E. MBBS (Hons),Stocker,Sophie L.PhD.

      Grand Rounds（大查房）
      1.通过透析降低HIV患者的多拉韦林暴露：大查房
      (Doravirine Exposure Decreased by Dialysis in a HIV Patient: A Grand Round)
      作者：Fromage,Yeleen PharmD,Codde,Cyrielle MD,et al.

      2. 除极高剂量万古霉素伴有肾毒性之外，一例罕见的万古霉素低暴露病例：大查房
      (An Unusual Case of Low Vancomycin Exposure Despite Extremely High Vancomycin Doses Accompanied by Renal Toxicity: A Grand Round)
      作者：van Schip,Anne M. PharmD;van Diemen,et al.

      3.在原发性胆汁性肝硬化患者中成功且安全的实时TDM指导使用低剂量伊舒康唑治疗侵袭性肺和脑曲霉菌病：大查房/病例研究
      (Successful and Safe Real-Time TDM-Guided Treatment of Invasive Pulmonary and Cerebral Aspergillosis Using Low-Dose Isavuconazole in a Patient with Primary Biliary Cirrhosis: Grand Round/A Case Study)
      作者：Cojutti,Pier Giorgio MD,PhD; Rinaldi,Matteo MD,et al.

      Review Article（综述文章）
      1.人工智能和机器学习方法促进治疗药物管理和已知模型的精准给药
      (Artificial Intelligence and Machine Learning Approaches to Facilitate Therapeutic Drug Management and Model-Informed Precision Dosing)
      作者：Poweleit,Ethan A. BS;Vinks,Alexander A.PharmD,PhD,et al.

      2.中国治疗药物监测现状调查
      (A Survey of Therapeutic Drug Monitoring Status in China)
      作者：Yin,Tao;Liang,Hongyan;Huang,Qi;Zhou, Boting;Tang,et al.

      3.优化妊娠期妇女治疗药物监测:关键文献综述
      (Optimizing Therapeutic Drug Monitoring in Pregnant Women: A Critical Literature Review)
      作者：Moreira,Fernanda de Lima PhD;Benzi,et al.

      4.免疫抑制治疗中的仿制药——这是治疗药物监测的挑战吗?
       (Generic Medicinal Products in Immunosuppressive Therapy—Should It be a Challenge for Therapeutic Drug Monitoring?)
      作者：Kocur,Arkadiusz Pharm,MSc; Kunicki,Paweł K.et al.

      5.COVID-19患者免疫抑制药物联合Nirmatrelvir/Ritonavir治疗药物监测及剂量调整
      (Therapeutic Drug Monitoring and Dosage Adjustments of Immunosuppressive Drugs When Combined With Nirmatrelvir/Ritonavir in Patients With COVID-19)
      作者：Lemaitre,Florian PharmD, PhD;Budde,Klemens MD;et al.

      6.使用治疗药物监测和药代动力学-药效学协议优化抗菌药物管理计划:成本效益回顾
      (Optimization of Antimicrobial Stewardship Programs Using Therapeutic Drug Monitoring and Pharmacokinetics–Pharmacodynamics Protocols: A Cost-Benefit Review)
      作者：Telles,João Paulo MD, PhD;Morales,Ronaldo Jr PharmD;et al.

      7.为什么产品信息不应该一成不变:利奈唑胺治疗药物监测十年的教训:一份意见文件
      (Why Product Information Should not be Set in Stone: Lessons from a Decade of Linezolid Therapeutic Drug Monitoring: An Opinion Paper)
      作者：Marriott,Deborah J. E. PhD;Cattaneo,Dario Ph.

      Original Article（原创文章）
      1.新型西门子亲和铬介导免疫测定法的分析性能——依维莫司测定法及其与热定量微球系统的互换性——用于实体器官移植后患者常规治疗药物监测
      (Analytical Performance of the New Siemens Affinity Chrome-Mediated Immunoassay Everolimus Assay and Its Interchangeability With the Thermo Quantitative Microsphere System for Routine Therapeutic Drug Monitoring of Patients After Solid Organ Transplantation)
      作者：Ialongo,Cristiano MD,PhD;Sapio,Maria MD;Angeloni,Antonio MD,PhD.

      2.容积吸收微采样法用于肝移植患者依维莫司治疗药物监测
      (Volumetric Absorptive Microsampling for the Therapeutic Drug Monitoring of Everolimus in Patients Who Have Undergone Liver Transplant)
      作者：Yoo,Seungji MS;Kim,Giseob PharmD;Kim,Soyeon PharmD;et al.

      3.心脏移植受者血液、细胞和组织钙调磷酸酶抑制剂的药代动力学-药效学关系：体内研究
      (Blood, Cellular, and Tissular Calcineurin Inhibitors Pharmacokinetic–Pharmacodynamic Relationship in Heart Transplant Recipients: The INTRACAR Study)
      作者：Coste,Gwendal PhD;Chabanne,Céline MD;Tron,Camille PhamD,et al.

      4.测量血清韦多利珠单抗和韦多利单抗抗体：商业试验与韦多利珠单抗临床开发试验的比较
      (Measuring Serum Vedolizumab and Vedolizumab Antibodies: Comparison of Commercial Assays with the Vedolizumab Clinical Development Assay)
      作者：Vande Casteele,Niels PharmD,PhD;Yang,Lili MS;Dobler,et al.

      5.用于浓度-时间曲线下面积的新型软件程序SAKURA-TDM的开发和评估——万古霉素给药引导：简报
      (Development and Evaluation of a Novel Software Program, SAKURA-TDM, for Area Under the Concentration-Time Curve–Guided Vancomycin Dosing: A Short Communication)
      作者：Horita,Yasuhiro PhD;Asaoka,Minami BS;Iida,Moeko BS;Kato,et al.

      6.托布霉素治疗成人囊性纤维化身高给药方案的新建议：人群药代动力学分析
      (New Recommendations of a Height-Based Dosing Regimen of Tobramycin for Cystic Fibrosis in Adults: A Population Pharmacokinetic Analysis)
      作者：Koloskoff,Kevin PharmD;Thirion,Daniel J. G.PharmD;Matouk,et al.

      7.用于治疗成人囊性纤维化肺加重的基于身高的妥布霉素初始剂量Nomogram的开发和评估
      (Development and Evaluation of a Height-Based Tobramycin Initial Dosing Nomogram for the Treatment of Adult Cystic Fibrosis Pulmonary Exacerbations)
      作者：El Hassani,Mehdi MSc;Thirion,Daniel J. G. PharmD;Koloskoff,et al.

      Short Communication（简报）
      1.局部枸橼酸盐抗凝持续肾置换过程中哌拉西林-他唑巴坦和万古霉素的清除率
      (Clearance of Piperacillin–Tazobactam and Vancomycin During Continuous Renal Replacement With Regional Citrate Anticoagulation)
      作者：Sharrock, Lucy;Ankravs,Melissa J;Deane,Adam M;Rechnitzer,et al.

      2.剂量适当之外，更昔洛韦在儿童中的亚治疗性暴露：简报
      (Subtherapeutic Exposure of Ganciclovir in Children Despite Appropriate Dosing: A Short Communication)
      作者：Marfil,Sjanene MSc;Märtson,Anne-Grete PhD;Toren-Wielema,et al.

      3.对乙酰氨基酚过量服用后风险评估失败—简报
      (Failure of Risk Assessment After Paracetamol Overdose—A Short Communication)
      作者：Boussetta-Charfi,Oulfa MSc;D'Andon,Cornélie Fanton PharmD;et al.

      4.急性羟丁酸钠中毒—一份病例报告和文献回顾
      (Acute Sodium Oxybate Intoxication: A Case Report and Review of the Literature)
      作者：Drevin, Guillaume MD;Briet,Marie MD,PhD;Ferec,Severine MSc;et al.

      Letters to the Editor （致编辑的信）
      1.使用富马酸替诺福韦治疗HIV感染者的血浆谷浓度：抗逆转录病毒类还是个体药物效应？
      (Tenofovir Plasma Trough Concentrations in People Living with HIV Treated with Tenofovir Disoproxyl Fumarate: Antiretroviral Class or Individual Drug Effect?)
      作者：Cattaneo,Dario PhD;Bonora,Stefano MD;Meraviglia,Paola MD;et al.